文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

不同医疗环境中可预防患者伤害的发生率、严重程度与性质:系统评价与Meta分析

Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2019-07-17
一句话结论全球医疗环境中约每20例患者有1例遭受可预防伤害,其中12%为严重或致死性,药物与治疗相关事件占比最高。

该系统评价与Meta分析检索2000年1月至2019年1月多数据库,纳入70项观察性研究、共337 025例患者。汇总可预防患者伤害发生率为6%(95%CI 5%~7%),其中12%(95%CI 9%~15%)为严重或导致死亡。药物相关事件(25%,95%CI 16%~34%)和其他治疗相关事件(24%,95%CI 21%~30%)占比最大。与综合医院相比,可预防伤害在重症监护或外科等高级专科更常见(回归系数b=0.07,95%CI 0.04~0.10)。

要点

  • 汇总可预防患者伤害发生率为6%(95%CI 5%~7%),即约每20例患者有1例遭受可预防伤害。
  • 可预防伤害中12%(95%CI 9%~15%)为严重或导致死亡。
  • 药物相关事件占可预防伤害的25%(95%CI 16%~34%),其他治疗相关事件占24%(95%CI 21%~30%)。
  • 与综合医院相比,可预防伤害在重症监护或外科等高级专科更常见(回归系数b=0.07,95%CI 0.04~0.10)。

适用人群与场景

  • 全球范围内接受医疗照护的患者,证据主要来自综合医院,涵盖重症监护或外科等高级专科。

研究设计与关键结果

  • 系统评价与Meta分析,纳入70项观察性研究、共337 025例患者,检索2000年1月至2019年1月文献。
  • 可预防患者伤害汇总发生率为6%(95%CI 5%~7%)。
  • 可预防伤害中严重或导致死亡的比例为12%(95%CI 9%~15%)。
  • 药物相关事件占25%(95%CI 16%~34%),其他治疗相关事件占24%(95%CI 21%~30%)。
  • 与综合医院相比,可预防伤害在重症监护或外科等高级专科更常见(回归系数b=0.07,95%CI 0.04~0.10)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入观察性研究。
  • 采用随机效应Meta分析,并行单变量和多变量Meta回归,用I²统计量量化异质性并评估发表偏倚。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,制定和实施针对可预防患者伤害的循证缓解策略,可带来医疗服务质量的重大改善,并可能更具成本效益。
  • 原文指出,针对可预防患者伤害而非整体患者伤害(可预防与不可预防)的具体质量改进实践有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To systematically quantify the prevalence, severity, and nature of preventable patient harm across a range of medical settings globally.

DESIGN: Systematic review and meta-analysis.

DATA SOURCES: Medline, PubMed, PsycINFO, Cinahl and Embase, WHOLIS, Google Scholar, and SIGLE from January 2000 to January 2019. The reference lists of eligible studies and other relevant systematic reviews were also searched.

REVIEW METHODS: Observational studies reporting preventable patient harm in medical care. The core outcomes were the prevalence, severity, and types of preventable patient harm reported as percentages and their 95% confidence intervals. Data extraction and critical appraisal were undertaken by two reviewers working independently. Random effects meta-analysis was employed followed by univariable and multivariable meta regression. Heterogeneity was quantified by using the I2 statistic, and publication bias was evaluated.

RESULTS: Of the 7313 records identified, 70 studies involving 337 025 patients were included in the meta-analysis. The pooled prevalence for preventable patient harm was 6% (95% confidence interval 5% to 7%). A pooled proportion of 12% (9% to 15%) of preventable patient harm was severe or led to death. Incidents related to drugs (25%, 95% confidence interval 16% to 34%) and other treatments (24%, 21% to 30%) accounted for the largest proportion of preventable patient harm. Compared with general hospitals (where most evidence originated), preventable patient harm was more prevalent in advanced specialties (intensive care or surgery; regression coefficient b=0.07, 95% confidence interval 0.04 to 0.10).

CONCLUSIONS: Around one in 20 patients are exposed to preventable harm in medical care. Although a focus on preventable patient harm has been encouraged by the international patient safety policy agenda, there are limited quality improvement practices specifically targeting incidents of preventable patient harm rather than overall patient harm (preventable and non-preventable). Developing and implementing evidence-based mitigation strategies specifically targeting preventable patient harm could lead to major service quality improvements in medical care which could also be more cost effective.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Panagioti M, Khan K, Keers RN, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ. 2019. PMID: 31315828. doi:10.1136/bmj.l4185

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。